Preview

Pharmacokinetics and Pharmacodynamics

Advanced search

Bioequivalence study of ondansetron tablets by HPLC-MS

Abstract

Within the cross, a single, open, randomized study with a week washout period, the two sequences has been studied bioequivalence of tablet forms two ondansetron 18 volunteers (8 mg dosage). Plasma samples were analyzed by a validated HPLC-MS, tropisetron was used as the internal standard. Limit of quantification was 1 ng/ml. Analyzed for drugs following pharmacokinetic parameters were calculated: AUC0-t, Cmax, Tmax, MRT, Cmax/AUC ' 90% confidence interval for log-transformed values of AUC0-t was 0,9507 - 1,0037, of AUC(0-∞ ). was 0,9402-0,9974, of C was 0,9255 - 1,0095. The study concluded that bioequivalence compared ondansetron drugs.

About the Authors

E. S. Stepanova
Peoples' Friendship university of Russia
Russian Federation


M. V. Ovcharov
Peoples' Friendship university of Russia
Russian Federation


S. S. Barsegyan
Peoples' Friendship university of Russia
Russian Federation


S. M. Nikonova
Peoples' Friendship university of Russia
Russian Federation


V. V. Shilov
Science Center «Hygiene and Public Health»
Russian Federation


V. V. Chistyakov
Science Center «Hygiene and Public Health»
Russian Federation


References

1. Kris M.G., Hesketh P.J., Herrstedt J., Rittenberg C., Einhorn L.H., Grunberg S. et al. Consensus proposals for the prevention of acute and delayed vomiting and nausea following high - emetic - risk chemotherapy. // Support Care Cancer 2005, Vol. 13:85-96.

2. Oge A., Alkis N., Oge O., Kartum A. Comparison of granisetron, ondansetron and tropisetron for control of vomiting and nausea induced by cisplatin. // J Chemother 2000, Vol. 12(1):105-108.

3. Steven M. Grunberg, and Paul J. Hesketh. Control of Chemotherapy-Induced Emesis. // The New England journal of medicine, 1993, Vol. 329:1790-1796.

4. Stiakaki E., Savvas S., Lydaki E., Bolonaki I., Kouvidi E., Dimitriou H., et al. Ondansetron and tropisetron in the control of nausea and vomiting in children receiving combined cancer chemotherapy. // Pediatr Hematol Oncol. 1999, Vol. 16(2):101-108.

5. Yara Popst Armando, Simone Grigoleto Schramm, Marina de Freitas Silva, Eunice Kazue Kano. Bioequivalence assay between orally disintegrating and conventional tablet formulations in healthy volunteers. // International Journal of Pharmaceutics, 2009, Vol. 366, 149-153.

6. Guideline on bioanalytical method validation. // European Medicines Agency, 2011.

7. Методические рекомендации «Изучение биоэквивалентности воспроизведенных лекарственных средств, гл. 7 в «Руководство по экспертизе лекарственных средств. Том I. - М.: Гриф и К, 2013.


Review

For citations:


Stepanova E.S., Ovcharov M.V., Barsegyan S.S., Nikonova S.M., Shilov V.V., Chistyakov V.V. Bioequivalence study of ondansetron tablets by HPLC-MS. Pharmacokinetics and Pharmacodynamics. 2015;(1):21-26. (In Russ.)

Views: 663


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2587-7836 (Print)
ISSN 2686-8830 (Online)